Keywords: UK, NICE, Nexavar, Bayer

UK’s NICE again refuses Nexavar for liver cancer patients

Article | 08 September 2009

Print This

The UK’s National Institute for Health and Clinical Excellence (NICE), which advises on treatments under the National Health Service ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in